NovoCure (NVCR) Interest Coverage Ratio Growth (1y) (2015 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 27.50% |
| Mar 31, 2022 | -1,318.08% |
| Dec 31, 2021 | -390.65% |
| Sep 30, 2021 | -214.46% |
| Jun 30, 2021 | -613.34% |
| Mar 31, 2021 | 97.61% |
| Dec 31, 2020 | 4,121.37% |
| Sep 30, 2020 | 149.97% |
| Jun 30, 2020 | 163.96% |
| Mar 31, 2020 | 46.12% |
| Dec 31, 2019 | 102.19% |
| Sep 30, 2019 | 168.94% |
| Jun 30, 2019 | 138.97% |
| Mar 31, 2019 | 1.22% |
| Dec 31, 2018 | -112.22% |
| Sep 30, 2018 | 20.28% |
| Jun 30, 2018 | 65.18% |
| Mar 31, 2018 | 52.22% |
| Dec 31, 2017 | 57.44% |
| Sep 30, 2017 | 78.74% |
| Jun 30, 2017 | 89.40% |
| Mar 31, 2017 | 90.60% |
| Dec 31, 2016 | 87.32% |
| Sep 30, 2016 | 56.90% |
| Jun 30, 2016 | -116.03% |
| Mar 31, 2016 | -56.66% |
| Dec 31, 2015 | 70.17% |
| Sep 30, 2015 | 91.13% |